Weighing just 2 KG, in a hospital, small clinic or doctor’s surgery the fully portable Fetatrack DD250 can provide continuous foetal and vascular dopler. The unit operates from a mains electricity supply for 30 hours; alternatively the built-in rechargable batteries can be used. ‘The system has all the necessary facilities for accurate antenatal foetal assessment in one compact unit,’…
Designed for multi-applications (e.g. general imaging, obstetrics/gynaecology, abdomen, small parts, musculoskeletal, urology, vascular) MyLab 20Plus, manufactured by Esaote Biomedica Deutschland GmbH, can be customised to suit individual needs in a shared ultrasound department or clinic.
Philips has developed a proprietary technology for elastography that uses new strain analytics for signals captured on the IU22 volume linear transducer and yields a relative quantification of tissue stiffness, which is presented as statistical charts displayed alongside a colour-coded qualificative image superimposed on the B-mode screen.
‘Supremely portable and incredibly tough, the NanoMaxx ultrasound system combines Best in Class performance with affordability and simplicity,’ the Erlangen-based manufacturer SonoSite reports.
The University of Pennsylvania Health System, one of the largest health systems in the US, has awarded a $135 million contract for Integrated Service Management to Siemens Healthcare. Over the next seven years, Siemens will be servicing and ensuring around-the-clock availability of diagnostic systems and bio-medical devices from diverse manufacturers in the customer´s various hospitals.
During a gathering of clinicians, scientists and economists at this year's Medical Technology Congress (Treffpunkt für Medizintechnik) held in Berlin's Charité Hospital, all 17 lectures focused on cancer treatments. Bettina Döbereiner reports
Emphasising the crucial partnership of radiologists and urologists in the treatment of prostate cancer, Professor Arnulf Stenzl, Medical Director of Urology at the Tübingen University Hospital, explained that, throughout the phases of prostate cancer diagnosis and therapy - from primary diagnosis onward - imaging is indispensable.
The respiratory unit at Newcastle's Royal Victoria Infirmary (RVI) is using SonoSite's M-Turbo system for management of pleural effusions, particularly in patients with lung tumours.
Professor Wolfgang Heinrichs, of the AQAI Simulation Centre Mainz, Germany, notes that the 15th SESAM congress slogan "Europe-tradition and innovation in simulation", was born out by the choice of venue, the Mainz Simulation Centre was one of the first of its kind in Europe, and also hosted the 2000 SESAM congress.
Real-time Tissue Elastography, an ultrasound procedure that uses colour to differentiate clearly and unambiguously between malignant, hardened tissue and flexible, benign tissue could be the addition needed to have really effective breast cancer screening, according to independent radiologist, and specialist in Real-time Tissue Elastography Dr Bruno Scheffer from Nantes, France.
This newly developed digital ultrasound system is fully software orientated and features the latest broadband beamforming technology and ultra high-speed processing capability together with single crystal transducer technology. Combined with advanced ergonomic design, the system blends exceptional levels of user friendliness with superior image quality to guarantee maximum diagnostic confidence…
In comparing ultrasound with other medical imaging methods such as MRI and CT scans, a literature review of published studies in the May/June issue of Journal of Diagnostic Medical Sonography (JDMS) describes the use of ultrasound to provide an accurate diagnosis more cost effectively than the alternatives.
With the possibilities of tissue elasticity measuring the diagnostic use of ultrasound has recently increased enormously; the opportunities and limits of this technology and its areas of application are continuously growing.
During KIMES, Karoline Laarmann (European Hospital) met with Joong-Ho Lee, Senior Executive Vice President of the ultrasound systems manufacturer MEDISON, the Korean firm that entered the ultrasound market in the 1980s and quickly established a global reputation for innovative developments (e.g. the firm produced the first commercial real-time 3-D ultrasound scanner).
Tissue removal is currently the only way to verify suspicious lesions in the prostate. It is also a key requirement before treating prostate carcinomas. The standard biopsy is performed with transrectal ultrasound (TRUS) to guide the needle in the right direction.
Although the majority of the 18,000 participants at ECR 2009 were radiologists, medical writer Rob Skelding reports that a specific session for radiographers was well attended. The event also underlined the value of their interpretive skills
‘Like the original Ode to the Liver, by Pablo Neruda, I too hope not to be betrayed by my liver. At least, not today!’
At ECR healthcare manufacturers not only introduced the latest products, but also the future technologies and trends that will have an impact on the market in the coming years.
In the Forbes China report this year, Edan is not only listed in the ‘Top 200 Chinese Enterprise with the Best Growing Potential´ (ranking 17th), but also this unlisted company's rapid rise on the score table made it the Forbes China star, being named as the Best Mover of Year 2008.
André Hoppen, Sales Manager VR Medico, Berlin, Germany, kicked off the finance item at the HMS agenda with his lecture “Do you know the right financing strategy for your hospital?”
New possibilities in breast ultrasound comprise techniques for optimizing image quality such as tissue harmonic imaging (THI) and frequency compounding (FC), tools for post-processing US raw data such as strain imaging (elastography), and the use of Realtime-Sonoelastography, PD Dr. Anke Thomas from the Charité in Berlin, Germany, introduced her speech at the Hitachi Symposium Realtime Tissue…
One of the most exciting innovations to be presented at this year's ECR (European Congress of Radiology), was be Viamo™. This pioneering product from Toshiba Medical Systems Europe is the first to offer premium technology in an ultraportable ultrasound system without compromising image quality or ease of use.
Delegates at the 2009 European Congress of Radiology (ECR) saw a series of presentations Friday unveiling new findings and key updates on digital breast tomosynthesis (DBT). As the body of research builds in this relatively unexplored field, the advantages and limitations of DBT compared with conventional full-field digital mammography (FFDM) and other modalities are becoming better defined.
Dr Giorgio Rizzatto, who heads the Department of Diagnostic Imaging at ASS 2 Isontina (including the Gorizia and Monfalcone hospitals) in NE Italy, works with nine radiologists, who examine and report on 80,000 clinical and screening breast examinations annually.